PeriphaGen
Dr. Brell is a medical oncologist specializing in the treatment of gastrointestinal cancers and focused on the causes and treatments of CIPN as faculty at the National Cancer Institute.
This person is not in the org chart
This person is not in any offices
PeriphaGen
PeriphaGen is a biopharmaceutical company focused on peripheral nerve gene therapy and committed to the development of innovative products for difficult-to-treat neurological disorders thereby improving patients' quality of life.